76.37
+7.49%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Globus Medical
From its filings with the US Securities and Exchange Commission
Globus Medical is based in Audubon, Pennsylvania and is incorporated in Delaware. Its shares trade on NYSE under the ticker GMED. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $2.94bn and net income of $537.9m. At that date it held total assets of $5.30bn and shareholders' equity of $4.57bn. By business, Musculoskeletal Solutions brought in 95.2% of revenue, followed by Enabling Technologies at 4.8%. By region, United States accounted for 80.6%, followed by International at 19.4%.
Globus Medical, Inc. (together, as applicable, with its consolidated subsidiaries, “Globus,” the “Company,” “we,” “us” or “our”), headquartered in Audubon, Pennsylvania, is a medical device company that develops and commercializes healthcare solutions whose mission is to improve the quality of life of patients with musculoskeletal disorders. Founded in 2003, Globus is committed to medical device innovation and delivering exceptional service to hospitals, ambulatory surgery centers and physicians to advance patient care and improve efficiency. Since inception, Globus has listened to the voice of the surgeon to develop practical solutions and products to help surgeons effectively treat patients and improve lives.
Globus is an engineering-driven company with a history of rapidly developing and commercializing advanced products and procedures to address treatment challenges. With 9 product launches in 2025 and operations across 65 countries worldwide, we offer a comprehensive portfolio of innovative and differentiated technologies that are used to treat a variety of musculoskeletal conditions. Although we manage our business globally within one reportable segment, we separate our products and services into two major categories: Musculoskeletal Solutions and Enabling Technologies.
Quoted from its 10-K, filed 24 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 8 Mar 2012
- Employees
- 6,000
- Website
- globusmedical.com ↗
- Head office
- 2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA, 19403
- Incorporated in
- DE
- Classification
- Surgical & Medical Instruments & Apparatus
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. David PaulExecutive Chairman of the Board, since 2017$3.1m
- Mr. Keith PfeilPresident, Chief Executive Officer$2.4m
- Mr. Kyle KlineChief Financial Officer
- Ms. Kelly HullerExecutive Vice President, General Counsel, Corporate Secretary$1.6m
- Mr. David DavidarIndependent Director, since 2003$421,524
- Dr. John DefordIndependent Director$466,896
- Mr. Robert DouglasIndependent Director$411,524
- Mr. Daniel LemaitreIndependent Director$421,524
- Ms. Leslie NorwalkIndependent Director$411,524
- Ms. Ann RhoadsIndependent Director$441,524
- Mr. James TobinIndependent Director$421,524
- Mr. Daniel WoltermanIndependent Director$411,524
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 25
- Environment
- 4
- Social
- 37
- Governance
- 34
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Globus Medical Inc has a strong market presence, positioning itself as a leading medical device manufacturer in the orthopedic sector. The company's extensive product portfolio showcases its ability to deliver innovative and high-quality solutions to meet the evolving needs of patients and healthcare professionals.
- They have a talented and experienced workforce, enabling them to attract top talent and maintain a competitive edge in research and development. This allows the company to continuously introduce new and advanced products to the market, further solidifying their position.
- Globus Medical Inc also possesses a robust distribution network, ensuring their products reach customers efficiently and effectively. This helps to expand their customer base and increase market share.
Weaknesses
- One weakness that Globus Medical Inc faces is their dependence on a limited number of key suppliers. Any disruption or quality issues with these suppliers could impact the company's ability to meet demand and maintain product quality standards.
- They also face certain regulatory challenges and compliance requirements, which can increase operational costs and introduce potential delays in bringing new products to market. This may impede their ability to quickly respond to changing market dynamics.
Opportunities
- The orthopedic medical device market is expected to grow significantly in the coming years due to an aging population and increasing prevalence of musculoskeletal disorders. This presents a significant opportunity for Globus Medical Inc to expand its product offerings and capture a larger market share.
- Advancements in technology, such as robotics and minimally invasive surgical techniques, provide an opportunity for the company to develop and introduce innovative products that improve patient outcomes and enhance surgical procedures.
- There is also potential for geographical expansion into new markets, both domestically and internationally, to tap into unexplored customer segments and diversify their revenue streams.
Threats
- The medical device industry is highly competitive, with the presence of both established players and new entrants. Intense competition can potentially impact pricing and market share for Globus Medical Inc.
- Changes in healthcare policies and regulations, as well as reimbursement policies, can have an adverse impact on the company's financial performance and ability to market and sell their products.
- Global economic uncertainties and fluctuations in currency exchange rates may present challenges for international operations and profitability.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.